Company Filing History:
Years Active: 2002-2003
Title: Innovations by Inventor Jin Su
Introduction
Jin Su is a notable inventor based in Toronto, Canada, recognized for his contributions to the field of virology. He holds three patents that focus on innovative methods to inhibit viral infections, particularly those related to human immunodeficiency virus (HIV). His work has significant implications for the development of new therapeutic strategies.
Latest Patents
One of Jin Su's latest patents is titled "Tripeptide amides that block viral infectivity and methods of use thereof." This invention relates to the discovery that tripeptide amides, which correspond to viral capsid sequences, can effectively inhibit viral infection, including HIV. The patent outlines medicaments comprising these tripeptide amides and methods for their use in preventing and treating viral infections.
Another significant patent is "Pentamer peptide amide, ALGPGNH2, which inhibits viral infectivity and methods of use thereof." This invention highlights a specific pentamer peptide amide that corresponds to a viral capsid sequence, demonstrating its potential to inhibit viral infections, including HIV. The patent details the medicaments that include this pentamer peptide amide and their applications in the prevention and treatment of viral infections.
Career Highlights
Jin Su is currently associated with Tripep Ab, a company dedicated to advancing research in peptide-based therapeutics. His innovative work in the field of virology has positioned him as a key figure in the development of new antiviral strategies.
Collaborations
Jin Su collaborates with esteemed colleagues, including David Van Der Spoel and Csaba Hetényi. Their combined expertise contributes to the advancement of research in viral inhibition and therapeutic development.
Conclusion
Jin Su's innovative patents and collaborative efforts in the field of virology underscore his significant contributions to medical science. His work holds promise for the development of effective treatments against viral infections, particularly HIV.